E Sullivan

Therapeutic advances in rheumatoid arthritis

Navigating the complexities of drug development for inflammatory bowel disease

The prevalence and types of discordance between physician perception and objective data from standardized measures of rheumatoid arthritis disease activity in real-world clinical practice in the US

Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment